Background: Diagnosis of specific benign disorders through endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is often challenging to cytopathologists due to the lack of tissue architecture on cytological specimens. The use of a Trucut biopsy needle (TCB) may improve the diagnostic accuracy of benign conditions over EUS-FNA. Aim: To compare the diagnostic accuracy of EUS-FNA and EUS-TCB in benign lesions. Methods: From October 2003 to November 2006, all patients who were referred for EUS-guided biopsy with a final diagnosis of a benign condition and underwent both FNA and TCB were included. A benign diagnosis was established either by EUS core biopsy, surgical biopsy or extended clinical/imaging follow-up (>6 months). Cytology and histological specimens from the FNA and TCB, respectively, were each reviewed by different pathologists. No on-site pathology assistance was available for either FNA or TCB. All cases were performed utilizing a 22-gauge cytology needle for FNA and a 19-gauge Trucut needle (Quickcore) for TCB. The linear array echoendoscope Olympus UCP-140 was used in all cases. McNemar's test and Fisher's exact test were utilized to compare TCB with FNA. Results: A total of 40 patients were included (18M, 22F) with a mean age of 56 years (range 19-82). The lesions were biopsied via the transesophageal (17), transgastric (22), and transduodenal (1) approaches. The final diagnoses were as follows: gastric GIST (15), esophageal leiomyoma (3), pancreatic amyloidosis (1), benign schwannoma (2), sarcoidosis (6) benign granuloma (2), hematoma (1), chronic pancreatitis (2), benign mediastinal lymphadenopathy (6), benign gastric glomus tumor (1) and benign adrenal adenoma (1). The average number of FNA passes was 4.72 (range 2-10) and TCB passes was 2.85 (range 0-6). TCB successfully obtained tissue in 35/40 patients (87.5%), with tissue obtained on the first pass in 24/40 patients (60.0%). Diagnostic accuracy of EUS-FNA was 60.0% (24/40), and for EUS-TCB was 77.5% (31/40) (p = 0.12). When combining FNA + TCB, the diagnostic accuracy increased to 87.5% (35/40) (p = 0.002 vs. FNA alone). Considering only patients in whom TCB provided tissue (35 patients), EUS-TCB had a diagnostic accuracy of 88.5% (31/35) (p = 0.008 vs. FNA alone, Fisher's exact test). One patient with mediastinal biopsy developed fever and chest pain treated with intravenous antibiotic; no surgery was needed. Conclusion: EUS-TCB provides a higher diagnostic accuracy than FNA in patients with benign lesions. When a benign condition is suspected, EUS-TCB should be performed first, and FNA should be used as rescue for cases when EUS-TCB fails to provide a core sample.
Read full abstract